Insulin autoantibodies before and after carbimazole therapy in Asian Indian patients with Graves' disease

Diabetes Research and Clinical Practice

Volumn 40, Issue 3, 1998, Pages 201-206

  Goswami, Ravinder ^a   Jayasuryan, Narayana ^b   Jaleel, Abdul ^a   Tandon, Nikhil ^a   Kochupillai, Narayana ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b International Centre for Genetic Engineering and Biotechnlogy   (India)

Author keywords

Asian Indians; Carbimazole; Graves' disease; Insulin autoantibodies

Indexed keywords

CARBIMAZOLE; INSULIN ANTIBODY;

ADULT; ARTICLE; ASIAN; BODY MASS; FEMALE; GRAVES DISEASE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; INDIAN; INSULIN RESPONSE; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST;

ADULT; ANTITHYROID AGENTS; CARBIMAZOLE; FEMALE; GRAVES DISEASE; HUMANS; INDIA; INSULIN ANTIBODIES; MALE;

EID: 0032104502     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00052-7     Document Type: Article

References (21)

1. Di Mario U., Perfetti R., Anastasi E.et al. Autoantibodies to insulin do appear in non diabetic patients with autoimmune disorders: comparison with antiimmunoglobulin antibodies and other autoimmune phenomena. Acta Endocrinol. (Copenhagen). 122:1990;303-308.
2. Harrop M., Caudwell J., Stojanovski C., Colman P.G. Insulin autoantibodies in patients with autoimmune diseases. Diabetes Res. Clin. Pract. 18:1992;107-112.
3. Vardi P., Modan-Mozes D., Ish-Shalom S., Soloveitzik L., Barzilai D., Modan M. Low titer, competitive insulin autoantibodies are spontaneously produced in autoimmune disease of the thyroid. Diabetes Res. Clin. Pract. 21:1993;161-166.
4. Takei M. Insulin autoantibodies produced by methimazole treatment in patients with Graves' disease. J. Tokyo Women's Med. Coll. 50:1980;54-68.
5. Eguchi Y., Hirata Y., Hasumi S. Statistical analysis of HLA-types of 26 patients with insulin autoimmune syndrome reported in Japan. J. Jpn. Diabetes. 32:1989;887-892.
6. Uchigata Y., Kuwata S., Tsushima T.et al. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB*0406. J. Clin. Endocrinol. Metab. 77:1993;249-254.
7. Armitage M., Franklyn J., Scott-Morgon L.et al. Insulin autoantibodies in Graves' disease - before and after carbimazole therapy. Diabetes Res. Clin. Pract. 8:1990;169-176.
8. Tandon N., Mehra N.K., Taneja V., Vaidya M.C., Kochupillai N. HLA antigens in Asian Indian patients with Graves' disease. Clin. Endocrinol. 33:1990;21-26.
9. A.P. Weetman, Autoimmune thyroid disease, in: A.P. Weetman (Ed.), Autoimmune Endocrine Disease, Cambridge University Press, Cambridge, 1991, pp. 66-162.
10. Goswami R., Bal C.S., Gupta N., Kochupillai N. Remission with carbimazole therapy and assessment of T4 suppression test as index of relapse in patients with Graves' disease in India. Indian J. Med. Res. 103:1996;270-275.
11. R. Volpe, Graves' disease, in: L.E. Braverman, R.D. Utiger (Eds.), Werners and Ingbar's The Thyroid - A Fundamental and Clinical Text, Lippincott, Philadelphia, PA, 1991, pp. 648-57.
12. Crooks J., Murray I.P.C., Wayne E.J. Statistical methods applied to the clinical diagnosis of thyrotoxicosis. Q. J. Med. 28:1959;211-234.
13. Srikanta S., Ganda O.P., Gleason R.E., Jackson R.A., Soeldner J.S., Eisenbarth G.S. Pre-type I diabetes: linear loss of beta cell response to intravenous glucose. Diabetes. 33:1984;717-720.
14. WHO Study Group Diabetes mellitus (1985). WHO Tech. Rep. Ser. 727:1984;1-113.
15. 125I containing acylating agents. J. Biochem. 133:1973;529-539.
16. 125I-labelled thyronines. Endocrinology. 102:1978;128-135.
17. Palmer J.P., Asplin C.M., Clemons P.et al. Insulin autoantibodies in insulin dependent diabetes before insulin treatment. Science. 222:1983;1337-1339.
18. Stumpo T.D.R., Llera A.S., Cardoso A.I., Poskus E. Solid versus liquid phase assays in detection of insulin antibodies. Influence of iodination site on labelled insulin binding. J. Immunol. Methods. 169:1994;241-249.
19. Hirata Y. Methimazole and insulin autoimmune syndrome with hypoglycemia. Lancet. ii:1983;1037-1038.
20. Hasumi S.T., Eguchi Y., Sato A., Morita C., Hirata Y. Insulin autoimmune syndrome is the third leading cause of spontaneous hypoglycemic attacks in Japan. Diabetes Res. Clin. Pract. 10:1990;211-214.
21. Weetman A.P., Tandon N., Morgan B.P. Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells. Lancet. 340:1992;633-636.